A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Ascending Dose Study to Assess the Activity, Safety and Tolerability of 2 Doses of AZD9056 for 4 Weeks in Patients with Active Rheumatoid Arthritis Receiving Methotrexate and/or Sulphasalazine

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].